טוען...
Thromboprophylaxis in COVID-19 – Rationale and considerations
The Corona Virus Disease-2019 (COVID-19) pandemic is associated with a very high incidence of thrombotic complications. The exact mechanisms for this excess risk for clots have not been elucidated although one of the often-quoted pathophysiological entity is immunothrombosis. Recognition of thrombot...
שמור ב:
| הוצא לאור ב: | Adv Biol Regul |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Published by Elsevier Ltd.
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8299150/ https://ncbi.nlm.nih.gov/pubmed/34332403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbior.2021.100819 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|